Raj Rajagovindan is an accomplished professional in the field of biomedical engineering with extensive experience in translational medicine and clinical development. Currently serving as Vice President of Translational Medicine at Voyager Therapeutics, Inc. since February 2025, Rajagovindan has previously held significant positions, including Vice President of Clinical Development Sciences at Vigil Neuroscience and Director of Biomarkers at Biogen. Additional roles include Senior Scientist III at AbbVie and Senior Scientist II at Abbott, alongside earlier experience as a Research Scientist at Orasi Medical. Raj Rajagovindan earned both a Master's and a PhD in Biomedical Engineering from the University of Florida between 2004 and 2009.
This person is not in the org chart
This person is not in any offices